Over-the-Counter (OTC) Drugs Market Size 2018-2026

The ‘Over-the-Counter (OTC) Drugs Market– Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2026,’ report provides analysis of the global Over-the-Counter (OTC) Drugs market for the period from 2016 to 2026, wherein 2019–2026 is the forecast period and 2018 is the base year. Data for 2017 has been included as historical information.

Free Download Sample Report Pages For Better understanding@ https://www.acumenresearchandconsulting.com/request-sample/1171

The report covers all trends and technologies expected to play a major role in growth of the global Over-the-Counter (OTC) Drugs market during the forecast period. It highlights drivers, restraints, and opportunities expected to influence the market from 2019 to 2026. The study provides a holistic perspective on the Over-the-Counter (OTC) Drugs market, in terms of revenue (in US$ Mn) and volume (in million units), across different regions such as North America, Europe, Asia Pacific, Middle East & Africa, and South America. The report highlights key trends affecting the Over-the-Counter (OTC) Drugs market at the global level. Prominent countries/sub-regions covered in the report include the U.S., Canada, Germany, France, the U.K., Italy, Russia, India, China, Japan, South Korea, South East Asia, GCC, South Africa, and Brazil.

By Product

  • Analgesics
  • Cold
  • Cough & Flu Products
  • Weight Loss Products
  • Gastrointestinal Products
  • Skin Products
  • Mineral and Vitamin Supplements
  • Sleeping Aids
  • Ophthalmic Products

By Region


  • North America
    U.S.
    Canada


  • Europe
    UK
    Germany
    France
    Italy
    Spain
    Russia
    Poland
    Rest of Europe


  • Asia-Pacific
    China
    Japan
    India
    Australia
    South Korea
    Taiwan
    Rest of Asia-Pacific


  • Latin America
    Brazil
    Chile
    Argentina
    Rest of Latin America


  • Middle East and Africa (MEA)
    South Africa
    Saudi Arabia
    Qatar
    Kuwait
    Rest of MEA

This report analyzes and forecasts the market for Over-the-Counter (OTC) Drugs at the global and regional levels. The market has been forecast in terms of revenue (in US$ Mn) and volume (in million units) from 2019 to 2026. The study includes drivers and restraints of the global market. It also covers the anticipated impact of these drivers and restraints during the forecast period.

The report comprises detailed ecosystem analysis, which provides a comprehensive view of the global Over-the-Counter (OTC) Drugs market. Porter’s five forces model has also been included to help understand the competition landscape of the market. Additionally, current indicators of diverse macro-economic factors are contextualized under key market indicators.

Research Methodology

Secondary research sources that are typically referred to include, but are not limited to company websites, annual reports, financial reports, broker reports, investor presentations, SEC filings, internal and external proprietary databases, relevant patent and regulatory databases, national government documents, statistical databases, market reports, news articles, press releases, webcasts specific to companies operating in the market, national government documents, statistical databases, and Factiva.

Primary research involves e-mail interactions, telephonic interviews, and face-to-face interviews conducted for each market segment across geographies. ARC conducts primary interviews on an ongoing basis with market participants and commentators in order to validate the data and analysis. Primary interviews provide firsthand information on market size, market trends, growth trends, competition landscape, and market outlook. These help validate and strengthen secondary research findings. They also help develop the analysis team’s expertise and market understanding.

Market Participants

The key players involved in the Over-the-Counter (OTC) drugs market includes companies such as Johnson & Johnson, Cipla, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories, Merck KGaA, Bayer, Pfizer, Alkem Laboratories Limited, GloxoSmithKline, Sanofi, Takeda, Glenmark Pharmaceuticals Limited, and others. The manufacturers of Over-the-Counter (OTC) drugs are focusing on developing drugs as per the regulations and standards enforced by governments and different organizations and associations.

Table of Contents

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Over-the-Counter (OTC) Drugs
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Over-the-Counter (OTC) Drugs Market By Product
1.2.2.1. Global Over-the-Counter (OTC) Drugs Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global Over-the-Counter (OTC) Drugs Market Revenue Share By Product in 2017
1.2.2.3. Analgesics
1.2.2.4. Cold
1.2.2.5. Cough & Flu Products
1.2.2.6. Weight Loss Products
1.2.2.7. Gastrointestinal Products
1.2.2.8. Skin Products
1.2.2.9. Mineral and Vitamin Supplements
1.2.2.10. Sleeping Aids
1.2.2.11. Ophthalmic Products
1.2.2.12. Others
1.2.3. Over-the-Counter (OTC) Drugs Market by Geography
1.2.3.1. Global Over-the-Counter (OTC) Drugs Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.3.2. North America Over-the-Counter (OTC) Drugs Market Revenue and Growth Rate (2015-2026)
1.2.3.3. Europe Over-the-Counter (OTC) Drugs Market Revenue and Growth Rate (2015-2026)
1.2.3.4. Asia-Pacific Over-the-Counter (OTC) Drugs Market Revenue and Growth Rate (2015-2026)
1.2.3.5. Latin America Over-the-Counter (OTC) Drugs Market Revenue and Growth Rate (2015-2026)
1.2.3.6. Middle East and Africa (MEA) Over-the-Counter (OTC) Drugs Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Over-the-Counter (OTC) Drugs Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Over-the-Counter (OTC) Drugs Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Over-the-Counter (OTC) Drugs Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Over-the-Counter (OTC) Drugs Major Manufacturers in 2017

CHAPTER 4. OVER-THE-COUNTER (OTC) DRUGS MARKET BY PRODUCT

4.1. Global Over-the-Counter (OTC) Drugs Revenue By Product
4.2. Analgesics
4.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.3. Cold
4.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.4. Cough & Flu Products
4.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.5. Weight Loss Products
4.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.6. Gastrointestinal Products
4.6.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.7. Skin Products
4.7.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.7.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.8. Mineral and Vitamin Supplements
4.8.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.8.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.9. Sleeping Aids
4.9.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.9.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.10. Ophthalmic Products
4.10.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.10.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.11. Others
4.11.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.11.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 5. NORTH AMERICA OVER-THE-COUNTER (OTC) DRUGS MARKET BY COUNTRY

5.1. North America Over-the-Counter (OTC) Drugs Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.2. North America Over-the-Counter (OTC) Drugs Market Revenue Share Comparison, 2015 & 2026 (%)
5.3. U.S.
5.3.1. U.S. Over-the-Counter (OTC) Drugs Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
5.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
5.4. Canada
5.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
5.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
5.5. Mexico
5.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
5.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)

CHAPTER 6. EUROPE OVER-THE-COUNTER (OTC) DRUGS MARKET BY COUNTRY

6.1. Europe Over-the-Counter (OTC) Drugs Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.2. Europe Over-the-Counter (OTC) Drugs Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. UK
6.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
6.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
6.4. Germany
6.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
6.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
6.5. France
6.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
6.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
6.6. Spain
6.6.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
6.6.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
6.7. Rest of Europe
6.7.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
6.7.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)

CHAPTER 7. ASIA-PACIFIC OVER-THE-COUNTER (OTC) DRUGS MARKET BY COUNTRY

7.1. Asia-Pacific Over-the-Counter (OTC) Drugs Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.2. Asia-Pacific Over-the-Counter (OTC) Drugs Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. China
7.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
7.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
7.4. Japan
7.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
7.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
7.5. India
7.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
7.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
7.6. Australia
7.6.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
7.6.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
7.7. South Korea
7.7.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
7.7.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
7.8. Rest of Asia-Pacific
7.8.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
7.8.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)

CHAPTER 8. LATIN AMERICA OVER-THE-COUNTER (OTC) DRUGS MARKET BY COUNTRY

8.1. Latin America Over-the-Counter (OTC) Drugs Market Revenue and Growth Rate, 2015 – 2026 ($Million)
8.2. Latin America Over-the-Counter (OTC) Drugs Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. Brazil
8.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
8.4. Argentina
8.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
8.5. Rest of Latin America
8.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)

CHAPTER 9. MIDDLE EAST OVER-THE-COUNTER (OTC) DRUGS MARKET BY COUNTRY

9.1. Middle East Over-the-Counter (OTC) Drugs Market Revenue and Growth Rate, 2015 – 2026 ($Million)
9.2. Middle East Over-the-Counter (OTC) Drugs Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Saudi Arabia
9.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
9.4. UAE
9.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
9.5. Rest of Middle East
9.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)

CHAPTER 10. AFRICA OVER-THE-COUNTER (OTC) DRUGS MARKET BY COUNTRY

10.1. Africa Over-the-Counter (OTC) Drugs Market Revenue and Growth Rate, 2015 – 2026 ($Million)
10.2. Africa Over-the-Counter (OTC) Drugs Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. South Africa
10.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
10.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
10.4. Egypt
10.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
10.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
10.5. Rest of Africa
10.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
10.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)

CHAPTER 11. COMPANY PROFILE

11.1. Johnson & Johnson
11.1.1. Company Snapshot
11.1.2. Overview
11.1.3. Financial Overview
11.1.4. Product Portfolio
11.1.5. Key Developments
11.1.6. Strategies
11.2. Cipla
11.2.1. Company Snapshot
11.2.2. Overview
11.2.3. Financial Overview
11.2.4. Product Portfolio
11.2.5. Key Developments
11.2.6. Strategies
11.3. Sun Pharmaceutical Industries Ltd.
11.3.1. Company Snapshot
11.3.2. Overview
11.3.3. Financial Overview
11.3.4. Product Portfolio
11.3.5. Key Developments
11.3.6. Strategies
11.4. Dr. Reddy’s Laboratories
11.4.1. Company Snapshot
11.4.2. Overview
11.4.3. Financial Overview
11.4.4. Product Portfolio
11.4.5. Key Developments
11.4.6. Strategies
11.5. Merck KGaA
11.5.1. Company Snapshot
11.5.2. Overview
11.5.3. Financial Overview
11.5.4. Product Portfolio
11.5.5. Key Developments
11.5.6. Strategies
11.6. Bayer
11.6.1. Company Snapshot
11.6.2. Overview
11.6.3. Financial Overview
11.6.4. Product Portfolio
11.6.5. Key Developments
11.6.6. Strategies
11.7. Pfizer
11.7.1. Company Snapshot
11.7.2. Overview
11.7.3. Financial Overview
11.7.4. Product Portfolio
11.7.5. Key Developments
11.7.6. Strategies
11.8. Alkem Laboratories Limited
11.8.1. Company Snapshot
11.8.2. Overview
11.8.3. Financial Overview
11.8.4. Product Portfolio
11.8.5. Key Developments
11.8.6. Strategies
11.9. GloxoSmithKline
11.9.1. Company Snapshot
11.9.2. Overview
11.9.3. Financial Overview
11.9.4. Product Portfolio
11.9.5. Key Developments
11.9.6. Strategies
11.10. Sanofi
11.10.1. Company Snapshot
11.10.2. Overview
11.10.3. Financial Overview
11.10.4. Product Portfolio
11.10.5. Key Developments
11.10.6. Strategies
11.11. Takeda
11.11.1. Company Snapshot
11.11.2. Overview
11.11.3. Financial Overview
11.11.4. Product Portfolio
11.11.5. Key Developments
11.11.6. Strategies
11.12. Glenmark Pharmaceuticals Limited
11.12.1. Company Snapshot
11.12.2. Overview
11.12.3. Financial Overview
11.12.4. Product Portfolio
11.12.5. Key Developments
11.12.6. Strategies
11.13. Others
11.13.1. Company Snapshot
11.13.2. Overview
11.13.3. Financial Overview
11.13.4. Product Portfolio
11.13.5. Key Developments
11.13.6. Strategies

CHAPTER 12. RESEARCH APPROACH

12.1. Research Methodology
12.1.1. Initial Data Search
12.1.2. Secondary Research
12.1.3. Primary Research
12.2. Assumptions and Scope
REQUEST CUSTOMIZATION
Buy this premium research report – https://www.acumenresearchandconsulting.com/buy-now/0/1171